Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MF6:GR

6.796 EUR 0.122 1.76%

As of 06:15:12 ET on 06/02/2015.

Snapshot for MagForce AG (MF6)

Open: 7.219 Day's Range: 6.620 - 7.230 Volume: 85,021
Previous Close: 6.918 52wk Range: 4.500 - 7.500 1-Yr Rtn: +15.19%

Stock Chart for MF6

No chart data available.
  • MF6:GR 6.796
  • 1D
  • 1M
  • 1Y
6.918
Interactive MF6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MF6

Current P/E Ratio (ttm) 23.9848
Estimated P/E(12/2014) -
Relative P/E vs. DAX 1.3169
Earnings Per Share (EUR) (ttm) 0.2806
Est. EPS (EUR) (12/2014) -0.2070
Est. PEG Ratio -
Market Cap (M EUR) 161.02
Shares Outstanding (M) 23.92
30 Day Average Volume 69,780
Price/Book (mrq) 8.5214
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MF6

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MF6

Magforce AG develops medical technologies. The Company specializes in nanocancer therapy for treatment of cancerous tumors. Magforce's treatment uses nanoparticles containing ironoxide, which are injected into solid tumors in a procedure similar to a biopsy.

Benjamin J Lipps "Ben"Chairman-Mgmt Board/CEOChristian Von VolkmannCFO/Member-Mgmt Board
Hoda TawfikCOO & CMO:Therapy Dev
More Company Profile & Key Executives for MF6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil